Glaucoma is a disease that causes damage to the eye’s optic nerve because of a fluid buildup inside the eye. Damage to the optic nerve can slowly lead to loss of vision and blindness. Unfortunately, there is nothing a patient with glaucoma can do on their own to prevent their eye pressure from rising. While there is no cure for glaucoma, there are many different treatment options that help prevent the loss of eyesight caused by high eye pressure. These treatment options include eye drops, oral medications, lasers, and surgeries.
It has been a goal to develop methods to lower eye pressure with the least amount of side effects and risk.
Dr. Coleman, a fellowship-trained glaucoma specialist here at our Princeton, NJ, ophthalmology practice, is now performing a new, state-of-the-art technique to safely lower eye pressure in patients with certain types of open angle glaucoma. The iStent trabecular micro-bypass stent is a new surgical therapy for glaucoma. iStent is the smallest medical device ever approved by the FDA and is placed in your eye during cataract surgery.
In order to maintain a normal pressure in the eye, there is fluid constantly being made and drained from inside the eye. People with glaucoma have increased resistance in their eye’s drainage system, causing a buildup of fluid in the eye. The iStent is used to bypass the highest resistance point in the drainage system, allowing fluid to drain more easily. Patients who undergo iStent implantation during cataract surgery may be able to decrease their glaucoma drop burden or even get off glaucoma drops altogether.
The iStent is so small, you won’t be able to see or feel it after surgery but it will be continuously working to help reduce your eye pressure. It stays in the eye for a patient’s lifetime.
These are very exciting times for glaucoma therapy. New, safe techniques are emerging for lowering eye pressure to help preserve a patient’s vision throughout their lifetime. Most of these techniques deal with bypassing the eye’s drainage system or decreasing fluid production in the eye.
To learn more, contact us and one of our helpful staff will schedule your appointment with Dr. Coleman.